Despite his numerous successes, Shuvo Roy faces several challenges in his work. One major hurdle is the translational research gap, which involves moving innovations from the laboratory to clinical practice. Regulatory hurdles, funding limitations, and the need for extensive clinical trials are significant obstacles that must be overcome. Additionally, ensuring the long-term biocompatibility and safety of nanotechnology-based devices is a critical concern.
